INSIGHTS
July 1, 2026
Your Product Is Detained at the Port. Your Inventory Is Stuck. Your Customers Are Waiting. Now What?
Your product made the journey across the ocean.
It passed through manufacturing, packaging, shipping, customs paperwork, and weeks of logistics.
Then it arrived in the United States and immediately hit a regulatory traffic jam.
FDA detention notices can feel like a nightmare for food, beverage, dietary supplement, cosmetic, medical device, and OTC drug companies. Every day a shipment sits at the port can mean lost sales, unhappy customers, storage fees, supply chain disruptions, and difficult conversations with retailers.
The good news? A detention does not always mean the road ends there.
Why Does FDA Detain Products?
FDA may detain imported products for many reasons, including:
- Potential misbranding or labeling violations;
- Questions regarding ingredient legality;
- Evidence of contamination or adulteration;
- Current Good Manufacturing Practice (cGMP) concerns;
- Failure to meet applicable product requirements;
- A manufacturer or product appearing on an FDA Import Alert.
The key is understanding why the product was detained before choosing a response strategy.
The Biggest Mistake Companies Make
Panic.
The second biggest mistake?
Assuming the detention is merely a paperwork inconvenience.
A single detained shipment may reveal broader supply chain, manufacturing, labeling, or regulatory vulnerabilities that could impact future imports.
In other words, today’s shipment may be the messenger. Do not shoot it.
Your First Steps After an FDA Detention
1. Review the Detention Notice Carefully
Deadlines matter.
Companies generally have a limited opportunity to submit testimony, evidence, or documentation demonstrating that the product is admissible.
2. Gather the Right Records
This may include:
- Certificates of analysis;
- Manufacturing records;
- Supplier qualification documents;
- Product specifications;
- Testing results;
- Labeling and marketing materials;
- Prior FDA correspondence.
3. Develop a Long-Term Strategy
Depending on the circumstances, companies may pursue:
- A response to overcome the detention;
- Reconditioning options where permitted;
- Corrective actions with suppliers or manufacturers;
- Strategies to address Import Alert concerns.
Think Beyond This Shipment
The cost of an FDA import problem is rarely limited to storage fees.
Import issues can affect:
- Product availability;
- Customer contracts;
- Retail relationships;
- International suppliers;
- Future FDA scrutiny;
- Company valuation during investment or acquisition.
Companies that treat an FDA detention as a one-time inconvenience often find themselves having the same conversation with FDA again.
Usually with less enthusiasm.
The Bottom Line
An FDA import detention requires speed, strategy, and a thorough understanding of both FDA and customs requirements.
The companies that respond effectively are not simply trying to release one shipment—they are protecting their ability to access the U.S. market for years to come.
Experienced FDA and import counsel can help companies navigate detention responses, evaluate broader compliance risks, and develop practical solutions that protect their supply chains and their business.